To prohibit the use of funds for the rule entitled "Provisional Unlawful Presence Waivers of Inadmissibility for Certain Immediate Relatives" published by the Department of Homeland Security on January 3, 2013 (78 Fed. Reg. 535).

H.R. 15, (Border Security, Economic Opportunity, and Immigration Modernization Act), H.R. 140/S. 301 (Birthright Citizenship Act), H.R. 242 (Legal Agricultural Workforce Act), H.R. 425 (prevent funds from use carrying out administrative amnesty), H.R. 457 (Criminal Accountability Act), H.R. 457 (Criminal Alien Accountability Act), H.R. 459 (STEM Visa Act), H.R. 463 (reforms to prevent fraud and abuse of the U visa), H.R. 477 (Nuclear Family Priority Act), H.R. 478 (E-Verify Modernization Act), H.R. 502 (Electronic Employment Eligibility Verification and Illegal Immigration Control Act), H.R. 830 (SAVE Act), H.R. 1227 (STAPLE Act), H.R. 1354 (Jobs Originated through Launching Travel (JOLT) Act), H.R. 1772 (Legal Workforce Act), H.R. 1773 (AG Act), H.R. 1901 (Keeping Our Communities Safe Act), H.R. 2124 (Keeping the Promise of IRCA Act), H.R. 2131 (Supplying Knowledge Based Immigrants and Lifting Levels of STEM Visas Act), H.R. 2264 (CLEAR Act), H.R. 2278 (Strengthen and Fortify Enforcement Act), H.R. 2377 (ENLIST Act), H.R. 2630 (1986 Amnesty Transparency Act), H.R. 2631 (Visa Overstay Enforcement Act), H.R. 2745 (No Social Security for Illegal Immigrants Act), H.R. 2765 (Save Our Seasons Act), H.R. 3141 (Biometric Exit Improvement Act), H.R. 3163 (CIR ASAP Act), S. 169 (Immigration Innovation (I-Squared) Act), S. 223 (Visa Waiver Program Enhanced Security and Reform Act), S. 299 (to prevent abuse of immigration information for breaking federal law against sanctuary policies in policing), S. 302 (Voter Integrity Protection Act), S. 303 (STEM Jobs Act), S. 600 (H-1B and L-1 Visa Reform Act), S. 744 (Border Security, Economic Opportunity, and Immigration Modernization Act), H.R. 3000 (REVIVE Act), H.R. 3611 (DHS Immigration Accountability and Transparency Act), H.R. 3732 (Immigration Compliance Enforcement (ICE) Act), H.R. 3921/S. 1943 (IN-STATE Act), H.Res. 326 (opposing amnesty), S. 1059 (amnesty for military service)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 15, (Border Security, Economic Opportunity, and Immigration Modernization Act), H.R. 140/S. 301 (Birthright Citizenship Act), H.R. 242 (Legal Agricultural Workforce Act), H.R. 425 (prevent funds from use carrying out administrative amnesty), H.R. 457 (Criminal Accountability Act), H.R. 457 (Criminal Alien Accountability Act), H.R. 459 (STEM Visa Act), H.R. 463 (reforms to prevent fraud and abuse of the U visa), H.R. 477 (Nuclear Family Priority Act), H.R. 478 (E-Verify Modernization Act), H.R. 502 (Electronic Employment Eligibility Verification and Illegal Immigration Control Act), H.R. 830 (SAVE Act), H.R. 1227 (STAPLE Act), H.R. 1354 (Jobs Originated through Launching Travel (JOLT) Act), H.R. 1772 (Legal Workforce Act), H.R. 1773 (AG Act), H.R. 1901 (Keeping Our Communities Safe Act), H.R. 2124 (Keeping the Promise of IRCA Act), H.R. 2131 (Supplying Knowledge Based Immigrants and Lifting Levels of STEM Visas Act), H.R. 2264 (CLEAR Act), H.R. 2278 (Strengthen and Fortify Enforcement Act), H.R. 2630 (1986 Amnesty Transparency Act), H.R. 2631 (Visa Overstay Enforcement Act), H.R. 2745 (No Social Security for Illegal Immigrants Act), H.R. 2765 (Save Our Seasons Act), H.R. 3141 (Biometric Exit Improvement Act), S. 169 (Immigration Innovation (I-Squared) Act), S. 223 (Visa Waiver Program Enhanced Security and Reform Act), S. 299 (to prevent abuse of immigration information for breaking federal law against sanctuary policies in policing), S. 302 (Voter Integrity Protection Act), S. 303 (STEM Jobs Act), S. 600 (H-1B and L-1 Visa Reform Act), S. 744 (Border Security, Economic Opportunity, and Immigration Modernization Act), H.R. 3000 (REVIVE Act), H.R. 3611 (DHS Immigration Accountability and Transparency Act), H.R. 3732 (Immigration Compliance Enforcement (ICE) Act), H.Res. 326 (opposing amnesty), S. 1059 (amnesty for military service)

H.R. 15, (Border Security, Economic Opportunity, and Immigration Modernization Act), H.R. 140 (Birthright Citizenship Act), H.R. 242 (Legal Agricultural Workforce Act), H.R. 425, H.R. 457 (Criminal Accountability Act), H.R. 477 (Nuclear Family Priority Act), H.R. 478 (E-Verify Modernization Act), H.R. 483, H.R. 502 (Electronic Employment Eligibility Verification and Illegal Immigration Control Act), H.R. 830 (SAVE Act), H.R. 1354 (Jobs Originated through Launching Travel Act), H.R. 1772 (Legal Workforce Act), H.R. 1773 (AG Act), H.R. 2131 (Supplying Knowledge Based Immigrants and Lifting Levels of STEM Visas Act), H.R. 2264 (CLEAR Act), H.R. 2278 (Strengthen and Fortify Enforcement Act), H.R. 2630 (1986 Amnesty Transparency Act), H.R. 2631 (Visa Overstay Enforcement Act), H.R. 3141 (Biometric Exit Improvement Act), S. 169 (Immigration Innovation Act), S. 223 (Visa Waiver Program Enhanced Security and Reform Act), S. 744 (Border Security, Economic Opportunity, and Immigration Modernization Act)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Biofuels Production Tax Credit ExtensionTax Reform Renewable Chemicals/Bio-based Products Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-based Products Expansion of Master Limited Partnerships to Renewable Chemicals S. 1267: Qualifying Renewable Chemical Production Tax Credit Act of 2013 H.R. 1696/S. 795: Master Limited Partnerships Parity Act Vaccine Access/Financing Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill To Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines Capital Formation Investment Incentives H.R. 6599/S.3595: High Technology Small Business Research Incentives Act Reform of Passive Loss Rules Reform of Net Operating Loss Rules Reform of Capital Gains Rules Research & Development Tax Credit Extension Orphan Drug Tax Credit

Client expense: $1,960,000 · Firm income: Not reported

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Colombia Biologics Regulations Mexico Biologics Regulations Naming Health Regulatory Agency Review of Patents Brazil Colombia Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) Tax on Seasonal Influenza Vaccine H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Drug Safety and Review Supply Chain Integrity Pharmacy Compounding HR. 1919: The Safeguarding Americas Pharmaceuticals Act S. 957: Drug Supply Chain Security Act S. 959: Pharmaceutical Compounding Quality Act Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Sequestration of PDUFA Fees Implementation of S. 365: Budget Control Act Asia Pacific Economic Cooperation Forum Intellectual Property Issues Biologics RegulationsTransatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Regulatory Transparency Orphan Drug Tax Credit

H.R. 140 (Birthright Citizenship Act), H.R. 242 (Legal Agricultural Workforce Act), H.R. 425, H.R. 457 (Criminal Accountability Act), H.R. 477 (Nuclear Family Priority Act), H.R. 478 (E-Verify Modernization Act), H.R. 483, H.R. 502 (Electronic Employment Eligibility Verification and Illegal Immigration Control Act), H.R. 830 (SAVE Act), H.R. 1354 (Jobs Originated through Launching Travel Act), H.R. 1772 (Legal Workforce Act), H.R. 1773 (AG Act), H.R. 2131 (Supplying Knowledge Based Immigrants and Lifting Levels of STEM Visas Act), H.R. 2278 (Strengthen and Fortify Enforcement Act), S. 169 (Immigration Innovation Act), S. 223 (Visa Waiver Program Enhanced Security and Reform Act), S. 744 (Border Security, Economic Opportunity, and Immigration Modernization Act)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Biofuels Production Tax Credit Extension Accelerated Depreciation ExtensionResearch & Development Tax Credit Extension Startup Innovation Credit (Senator Coons Discussion Draft) Innovative Research and Competitiveness Act (Senator Carper Discussion Draft) Capital Formation Investment Incentives High Technology Small Business Research Incentives Act (Discussion Draft) Vaccine Access/Financing Tax for Seasonal Influenza Funding H.R. 425/S.391: A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Tax Reform Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-Based Products Expansion of Master Limited Partnerships to Renewable Chemicals

Client expense: $1,980,000 · Firm income: Not reported

Funding for National Institutes of Health H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Vaccine Access/Financing Tax for Seasonal Influenza Funding H.R. 425/S. 391: A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Adult Immunization Policies Adult Immunization Senate Discussion Draft 340B Drug Pricing Program HRSA Implementation of Program Changes Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Drug Safety and Review Implementation of S. 3187: The Food and Drug Administration Safety and Innovation Act Regulatory Reforms for Innovative Products Expedited Approval Pathways E-Pedigree and Anti-Counterfeiting Supply Chain Integrity Pharmacy Compounding Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Cures Acceleration Network Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014 Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biodefense Research, Development, and Procurement (Non-Funding Issues) H.R. 307: Pandemic and All-Hazards Preparedness Reauthorization Act Reimbursement for Innovative Products Medicare Part D Prescription Drug Program Medicare Part B Physician-Administered Products H.Con.Res. 25: House Budget Resolution (Democratic Caucus Substitute) H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 U.S./European Union High-Level Dialogue on Regulatory IssuesSequestration of PDUFA Fees H.R. 933: Consolidated and Further Continuing Appropriations Act for FY 2013 Implementation of S. 365: Budget Control Act TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuitcalsl Regulatory Transparency